Exp Mol Med.  2012 Sep;44(9):536-544.

Cyclooxygenase-2 inhibitors modulate skin aging in a catalytic activity-independent manner

Affiliations
  • 1Department of Biochemistry and Molecular Biology, Institute of Medical Sciences, Kangwon National University School of Medicine, Chuncheon 200-701, Korea. gshja@kangwon.ac.kr
  • 2Department of Anatomic Pathology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon 200-701, Korea.
  • 3Department of Biological Sciences, College of Natural Sciences, Kangwon National University, Chuncheon 200-701, Korea.
  • 4Department of Medical Biotechnology, College of Biomedical Science, Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon 200-701, Korea.
  • 5Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon 200-701, Korea.

Abstract

It has been proposed that the pro-inflammatory catalytic activity of cyclooxygenase-2 (COX-2) plays a key role in the aging process. However, it remains unclear whether the COX-2 activity is a causal factor for aging and whether COX-2 inhibitors could prevent aging. We here examined the effect of COX-2 inhibitors on aging in the intrinsic skin aging model of hairless mice. We observed that among two selective COX-2 inhibitors and one non-selective COX inhibitor studied, only NS-398 inhibited skin aging, while celecoxib and aspirin accelerated skin aging. In addition, NS-398 reduced the expression of p53 and p16, whereas celecoxib and aspirin enhanced their expression. We also found that the aging-modulating effect of the inhibitors is closely associated with the expression of type I procollagen and caveolin-1. These results suggest that pro-inflammatory catalytic activity of COX-2 is not a causal factor for aging at least in skin and that COX-2 inhibitors might modulate skin aging by regulating the expression of type I procollagen and caveolin-1.

Keyword

caveolin-1; cyclooxygenase inhibitors; procollagen; skin aging

MeSH Terms

Animals
Aspirin/administration & dosage
Catalysis
Caveolin 1/genetics/metabolism
Collagen Type I/genetics/metabolism
*Cyclooxygenase 2/metabolism/physiology
Cyclooxygenase 2 Inhibitors/*administration & dosage
Gene Expression Regulation
Mice
Nitrobenzenes/*administration & dosage
Pyrazoles/administration & dosage
Skin Aging/*drug effects/physiology
Sulfonamides/*administration & dosage
Tumor Suppressor Protein p53/genetics/metabolism
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr